Cargando…
Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
BACKGROUND: Image‐guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the accuracy of treatment delivery. However, a recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy either via IGRT or routine care (no daily IGRT) reported a stat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938750/ https://www.ncbi.nlm.nih.gov/pubmed/31742897 http://dx.doi.org/10.1111/1759-7714.13244 |
_version_ | 1783484088755159040 |
---|---|
author | Kuo, Yao‐Hung Fang, Hsin‐Yuan Lin, Yu‐Sen Lein, Ming‐Yu Yang, Chi‐Ying Ho, Shih‐Chi Li, Chia‐Chin Chien, Chun‐Ru |
author_facet | Kuo, Yao‐Hung Fang, Hsin‐Yuan Lin, Yu‐Sen Lein, Ming‐Yu Yang, Chi‐Ying Ho, Shih‐Chi Li, Chia‐Chin Chien, Chun‐Ru |
author_sort | Kuo, Yao‐Hung |
collection | PubMed |
description | BACKGROUND: Image‐guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the accuracy of treatment delivery. However, a recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy either via IGRT or routine care (no daily IGRT) reported a statistically significant worse overall survival for those treated with IGRT. This raised the concern regarding the effectiveness of IGRT for definitive concurrent chemoradiotherapy (dCCRT) for locally advanced esophageal squamous cell carcinoma (LA‐ESqCC). METHODS: Eligible LA‐ESqCC patients diagnosed between 2011 and 2015 were identified via the Taiwan Cancer Registry. We estimated propensity scores to construct a 1:1 propensity‐score‐matched groups and balance observable potential confounders. The hazard ratio (HR) of death as well as other outcomes was compared between IGRT and non‐IGRT matched groups during the entire follow‐up period. The impact of additional covariables was considered in the sensitivity analysis. RESULTS: Our study population included 590 patients in the primary analysis. The HR for death when IGRT was compared with non‐IGRT was 0.92 (95% confidence interval 0.77–1.10, P = 0.35). There were also no significant differences for other outcomes or sensitivity analyses. CONCLUSIONS: In this updated nonrandomized study using real world data, we found that the overall survival of LA‐ESqCC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the hazard ratio was less than unity, ie, in favor of IGRT. The results should be interpreted with caution given the nonrandomized design and RCTs are needed to clarify our findings. KEY POINTS: Significant findings of the study: The OS of LA‐ESqCC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the hazard ratio was less than unity, ie, in favor of IGRT. What this study adds: In this updated nonrandomized study using real world data with additional potential confounders, our study provided a reasonable tentative evidence of lack of RCT as suggested in the literature. |
format | Online Article Text |
id | pubmed-6938750 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-69387502020-01-06 Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy Kuo, Yao‐Hung Fang, Hsin‐Yuan Lin, Yu‐Sen Lein, Ming‐Yu Yang, Chi‐Ying Ho, Shih‐Chi Li, Chia‐Chin Chien, Chun‐Ru Thorac Cancer Original Articles BACKGROUND: Image‐guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the accuracy of treatment delivery. However, a recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy either via IGRT or routine care (no daily IGRT) reported a statistically significant worse overall survival for those treated with IGRT. This raised the concern regarding the effectiveness of IGRT for definitive concurrent chemoradiotherapy (dCCRT) for locally advanced esophageal squamous cell carcinoma (LA‐ESqCC). METHODS: Eligible LA‐ESqCC patients diagnosed between 2011 and 2015 were identified via the Taiwan Cancer Registry. We estimated propensity scores to construct a 1:1 propensity‐score‐matched groups and balance observable potential confounders. The hazard ratio (HR) of death as well as other outcomes was compared between IGRT and non‐IGRT matched groups during the entire follow‐up period. The impact of additional covariables was considered in the sensitivity analysis. RESULTS: Our study population included 590 patients in the primary analysis. The HR for death when IGRT was compared with non‐IGRT was 0.92 (95% confidence interval 0.77–1.10, P = 0.35). There were also no significant differences for other outcomes or sensitivity analyses. CONCLUSIONS: In this updated nonrandomized study using real world data, we found that the overall survival of LA‐ESqCC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the hazard ratio was less than unity, ie, in favor of IGRT. The results should be interpreted with caution given the nonrandomized design and RCTs are needed to clarify our findings. KEY POINTS: Significant findings of the study: The OS of LA‐ESqCC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the hazard ratio was less than unity, ie, in favor of IGRT. What this study adds: In this updated nonrandomized study using real world data with additional potential confounders, our study provided a reasonable tentative evidence of lack of RCT as suggested in the literature. John Wiley & Sons Australia, Ltd 2019-11-19 2020-01 /pmc/articles/PMC6938750/ /pubmed/31742897 http://dx.doi.org/10.1111/1759-7714.13244 Text en © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Kuo, Yao‐Hung Fang, Hsin‐Yuan Lin, Yu‐Sen Lein, Ming‐Yu Yang, Chi‐Ying Ho, Shih‐Chi Li, Chia‐Chin Chien, Chun‐Ru Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
title | Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
title_full | Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
title_fullStr | Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
title_full_unstemmed | Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
title_short | Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
title_sort | effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938750/ https://www.ncbi.nlm.nih.gov/pubmed/31742897 http://dx.doi.org/10.1111/1759-7714.13244 |
work_keys_str_mv | AT kuoyaohung effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT fanghsinyuan effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT linyusen effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT leinmingyu effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT yangchiying effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT hoshihchi effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT lichiachin effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy AT chienchunru effectivenessofimageguidedradiotherapyforlocallyadvancedesophagealsquamouscellcarcinomapatientstreatedwithdefinitiveconcurrentchemoradiotherapy |